HACKETT GROUP, INC. HCKT
The Hackett Group, Inc. (NASDAQ: HCKT) is a global, IP platform-based generative artificial intelligence ("Gen AI") strategic advisory, business transformation, and enterprise application implementation firm. We combine proprietary benchmarking and best-practice process intelligence intellectual property ("IP") with Gen AI–enabled delivery platforms to help clients identify, prioritize, design, and implement high-impact improvements across enterprise functions, including supply chain and operations, finance, human resources, information technology, procurement and corporate services, as well as selected enterprise application implementation services, including Oracle, SAP, OneStream, and eProcurement applications.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.6M | $313.9M | $296.6M | $293.7M | $278.8M | $239.5M | $282.5M | $285.9M | $276.6M | $279.8M |
| Cost of revenue | $188.5M | $190.6M | $180.2M | $178.2M | $173.1M | $166.4M | $185.7M | $186.3M | $183.3M | $186.2M |
| Gross profit | $117.2M | $123.2M | $84.4M | $89.5M | $83.8M | $52.4M | $96.8M | $99.6M | $93.3M | $93.6M |
| SG&A | $90.5M | $78.5M | $65.9M | $61.0M | $59.2M | $54.0M | $62.1M | $64.1M | $63.3M | $60.1M |
| Total operating expenses | $282.1M | $269.3M | $247.3M | $238.5M | $232.3M | $230.8M | $251.1M | $252.3M | $247.9M | $246.3M |
| Operating income | $23.5M | $44.6M | $49.3M | $55.2M | $46.5M | $8.6M | $31.3M | $33.6M | $28.7M | $33.5M |
| Interest expense | $1.7M | $1.6M | $3.2M | $144.0K | $95.0K | $126.0K | $311.0K | $638.0K | $584.0K | $387.0K |
| Pre-tax income | $21.8M | $43.0M | $46.0M | $55.1M | $46.4M | $8.5M | $31.0M | $32.9M | $28.1M | $33.1M |
| Income tax | $8.9M | $13.4M | $11.9M | $14.3M | $4.8M | $2.9M | $7.7M | $5.6M | $2.6M | $12.5M |
| Net income | $12.9M | $29.6M | $34.2M | $40.8M | $41.5M | $5.5M | $23.3M | $23.9M | $27.4M | $21.5M |
| EPS, basic | 0.47 | 1.08 | 1.26 | 1.30 | 1.38 | 0.18 | 0.78 | 0.81 | 0.95 | 0.74 |
| EPS, diluted | 0.46 | 1.05 | 1.24 | 1.28 | 1.26 | 0.17 | 0.72 | 0.74 | 0.85 | 0.66 |
| Shares, diluted (wtd. avg.) | $27.9M | $28.1M | $27.6M | $32.0M | $32.9M | $32.4M | $32.5M | $32.3M | $32.2M | $32.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $18.2M | $16.4M | $21.0M | $30.3M | $45.8M | $49.5M | $26.0M | $13.8M | $17.5M | $19.7M |
| Receivables | — | — | — | — | — | $32.8M | $49.8M | $54.8M | $52.3M | $47.4M |
| Total current assets | $83.9M | $76.3M | $75.4M | $81.2M | $102.2M | $84.8M | $78.6M | $73.1M | $75.3M | $68.8M |
| Property, plant and equipment | $24.0M | $20.3M | $20.0M | $19.4M | $18.0M | $18.2M | $19.9M | $19.8M | $18.9M | $14.8M |
| Goodwill | $90.7M | $89.8M | $84.2M | $83.5M | $85.1M | $85.3M | $84.6M | $84.2M | $85.1M | $72.4M |
| Other intangibles | $3.3M | $2.3M | — | — | $159.0K | $1.2M | $2.1M | $3.1M | $5.5M | $2.7M |
| Total assets | $206.4M | $193.3M | $181.4M | $185.0M | $207.5M | $192.5M | $193.7M | $180.8M | $185.2M | $159.3M |
| Accounts payable | $6.3M | $6.5M | $7.6M | $8.7M | $7.7M | $6.1M | $8.5M | $7.4M | $8.4M | $9.1M |
| Total current liabilities | $48.8M | $53.1M | $49.9M | $59.6M | $54.9M | $42.6M | $43.7M | $44.2M | $51.4M | $55.8M |
| Long-term debt | $75.8M | $12.7M | $32.7M | $59.7M | — | — | — | $6.5M | $19.0M | $7.0M |
| Total liabilities | $138.3M | $77.7M | $91.3M | $126.7M | $63.7M | $51.7M | $56.1M | $57.2M | $78.0M | $73.0M |
| Retained earnings | $78.4M | $78.3M | $60.8M | $38.6M | $11.3M | -$17.4M | -$13.7M | -$25.4M | -$38.5M | -$56.6M |
| Total equity | $68.1M | $115.6M | $90.1M | $58.3M | $143.9M | $140.9M | $137.6M | $123.6M | $107.3M | $86.3M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $40.3M | $47.7M | $37.4M | $58.9M | $46.4M | $44.1M | $42.4M | $32.4M | $26.5M | $32.9M |
| Depreciation and amortisation | $5.2M | $3.9M | $3.4M | $3.4M | $4.4M | $4.5M | $3.2M | $2.5M | $2.4M | $2.5M |
| Stock-based compensation | $10.9M | $11.8M | $10.7M | $10.3M | $10.1M | $9.7M | $7.7M | $9.3M | $10.3M | $8.8M |
| Capital expenditure | $7.9M | $4.1M | $4.1M | $4.7M | $3.2M | $1.9M | $4.6M | $9.6M | $6.5M | $3.2M |
| Investing cash flow | -$8.6M | -$10.6M | -$4.1M | -$4.7M | -$3.2M | -$1.9M | -$5.6M | -$9.6M | -$17.5M | -$3.2M |
| Financing cash flow | -$29.8M | -$41.7M | -$42.6M | -$69.7M | -$46.7M | -$18.7M | -$24.7M | -$26.6M | -$11.2M | -$33.5M |
| Dividends paid | $12.9M | $12.1M | $12.0M | $10.4M | $12.9M | $14.9M | $11.2M | $10.0M | $8.7M | $7.2M |
| Buybacks | $69.1M | $6.4M | $734.0K | $116.6M | $13.0M | $2.4M | $7.8M | $4.8M | $15.7M | $34.1M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-082863.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $8.76B | 10.6x | -6.4% |
| G | Genpact LTD | $6.27B | 11.9x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.19B | 18.4x | 2.4% |
| EXPO | EXPONENT INC | $3.25B | 33.0x | 4.2% |
| HURN | Huron Consulting Group Inc. | $2.52B | 26.6x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.14B | 83.6x | 56.4% |
| ICFI | ICF International, Inc. | $1.58B | 17.8x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $735.5M | 58.1x | 14.9% |